ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 120 filers reported holding ARBUTUS BIOPHARMA CORP in Q1 2024. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 16,013,540 | $39,233,000 | 1.19% |
| ARMISTICE CAPITAL, LLC | 1,940,000 | $4,753,000 | 1.12% |
| DAFNA Capital Management LLC | 234,000 | $573,000 | 0.50% |
| Alpha Wave Global, LP | 1,655,162 | $4,055,000 | 0.43% |
| Telemetry Investments, L.L.C. | 150,000 | $368,000 | 0.21% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 5,294,945 | $12,972,000 | 0.18% |
| SABBY MANAGEMENT, LLC | 792,617 | $1,942,000 | 0.11% |
| K2 PRINCIPAL FUND, L.P. | 443,887 | $1,088,000 | 0.10% |
| Anson Funds Management LP | 105,085 | $257,000 | 0.08% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 25,000 | $61,000 | 0.03% |